Dimensional Fund Advisors’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.87M | Sell |
427,071
-148,241
| -26% | -$1.69M | ﹤0.01% | 2531 |
|
|
2025
Q1 | $6.84M | Buy |
575,312
+68,473
| +14% | +$814K | ﹤0.01% | 2399 |
|
|
2024
Q4 | $9.55M | Buy |
506,839
+5,270
| +1% | +$99.3K | ﹤0.01% | 2326 |
|
|
2024
Q3 | $11.3M | Sell |
501,569
-101,564
| -17% | -$2.28M | ﹤0.01% | 2251 |
|
|
2024
Q2 | $12.6M | Sell |
603,133
-363,320
| -38% | -$7.58M | ﹤0.01% | 2158 |
|
|
2024
Q1 | $14.2M | Sell |
966,453
-33,591
| -3% | -$494K | ﹤0.01% | 2159 |
|
|
2023
Q4 | $10.3M | Buy |
1,000,044
+42,001
| +4% | +$433K | ﹤0.01% | 2308 |
|
|
2023
Q3 | $7.53M | Buy |
958,043
+180,531
| +23% | +$1.42M | ﹤0.01% | 2383 |
|
|
2023
Q2 | $7.77M | Buy |
777,512
+143,995
| +23% | +$1.44M | ﹤0.01% | 2366 |
|
|
2023
Q1 | $5.63M | Buy |
633,517
+49,775
| +9% | +$442K | ﹤0.01% | 2448 |
|
|
2022
Q4 | $6.41K | Buy |
583,742
+249,017
| +74% | +$2.73K | ﹤0.01% | 2373 |
|
|
2022
Q3 | $4.36M | Buy |
334,725
+130,423
| +64% | +$1.7M | ﹤0.01% | 2474 |
|
|
2022
Q2 | $2.59M | Sell |
204,302
-33,223
| -14% | -$421K | ﹤0.01% | 2662 |
|
|
2022
Q1 | $3.33M | Buy |
237,525
+121,167
| +104% | +$1.7M | ﹤0.01% | 2666 |
|
|
2021
Q4 | $3.37M | Buy |
+116,358
| New | +$3.37M | ﹤0.01% | 2694 |
|